Anxiety studies

Stepped-Care Cognitive-Behavioral Treatment for Youth With ASD and Anxiety

This study has finished and is no longer accepting participants.

Countries

United States

Sponsor

Baylor College of Medicine

The Role of Mental Imagery on Approach Motivation and Behavioral Engagement in Social Anxiety

This study has finished and is no longer accepting participants.

Countries

Germany

Sponsor

Philipps University Marburg

Using CalmiGo to Manage Anxiety and Panic Attack Symptoms in the Emergency Department

This study has finished and is no longer accepting participants.

Countries

United States

Sponsor

Yves Duroseau

The iChill Project: can generalised anxiety disorder be prevented and treated using e-health interventions?

This study isn't currently recruiting.

Countries

Australia

Sponsor

Centre for Mental Health Research (CMHR) (Australia)

A 1-Year Open-Label Safety Extension Study of Pregabalin (CI-1008) in Patients With Anxiety Disorders

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Latvia

Sponsor

Pfizer Global Research & Development

A 52-WEEK OPEN-LABEL SAFETY STUDY OF PD 0332334 IN SUBJECTS WITH GENERALIZED ANXIETY DISORDER

This study ended early.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Hungary

Sponsor

Pfizer Inc., 235 East 42nd Street, New York, NY 10017

A double-blind, randomised, placebo-controlled, multicentre, relapse-prevention study with Lu AA21004 in patients with Generalised Anxiety Disorder (GAD)

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

France, Estonia, Finland, + 1 other

Sponsor

H. Lundbeck A/S

A Phase IV randomised controlled trial of the selective serotonin reuptake inhibitor Sertraline versus Cognitive Behavioural Therapy for anxiety symptoms in people with Generalised Anxiety Disorder...

This study ended early.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

United Kingdom

Sponsor

University College London Joint Research Office

A Placebo-Controlled Study of Pregabalin in Elderly Patients With Generalized Anxiety Disorder

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Latvia

Sponsor

Pfizer Global Research & Development

Duloxetine 60 to 120 mg Once Daily Compared with Placebo in the Prevention of Relapse in Generalized Anxiety Disorder

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Austria, Germany

Sponsor

Eli Lilly and Company Limited

Efficacy and safety of 2 doses of agomelatine (10 mg/day or 25 mg/day) versus placebo given orally for 12 weeks in non depressed out-patients with Generalized Anxiety Disorder. A 12-week randomise...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Finland, Poland, Slovakia

Sponsor

Institut de Recherches Internationales Servier

Efficacy and safety of agomelatine (25 mg/day with potential blinded adjustment at 50 mg/day) for 12 weeks in non-depressed out-patients with Generalized Anxiety Disorder. A 12-week randomised, dou...

This study ended early.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Czechia, Slovakia

Sponsor

Institut de Recherches Internationales Servier